What Is Private-Label Pharmaceutical Manufacturing? A Plain-Language Guide

Private-label pharmaceutical manufacturing — sometimes called third-party manufacturing or contract manufacturing — is the practice of a brand selling a medicine that is manufactured by someone else's licensed facility, under that brand's own name and packaging. It's how a huge share of the pharmaceutical products sold in India reach the market, and it's also how many new pharma brands get started without raising the capital needed to build and license their own plant.

The basic idea

Instead of building a factory, getting it licensed, hiring a production team, and managing quality control yourself, you partner with a manufacturer who already has all of that in place. You decide what to sell — the formulation, the dosage form, the packaging, the brand name — and the manufacturer handles how it gets made.

This isn't a shortcut around regulation. The manufacturer still needs to hold the relevant manufacturing licences for the product category, and the finished product still has to meet the same labelling and quality requirements as any other pharmaceutical product. What changes is who needs to hold which licences and do which work.

How the process generally works

While details vary by manufacturer and by product, the overall shape of a private-label arrangement tends to look like this:

1. Product selection. You choose a generic formulation (for example, a specific molecule, strength, and dosage form) that the manufacturer already has the capability and approvals to produce, or in some cases propose a new formulation for them to evaluate.
2. Manufacturer evaluation. You review the manufacturer's certifications, facility capabilities, and track record. This is the step most worth slowing down for — see our guide on evaluating a contract manufacturer.
3. Customization. You specify packaging details: blister type, bottle type, label design, carton design, pack size, and so on, within whatever options the manufacturer offers.
4. Quotation and agreement. The manufacturer quotes pricing based on order quantity (often in tiers — larger orders get a better per-unit price), minimum order quantity (MOQ), lead time, and payment terms.
5. Artwork and approval. You finalize label and carton artwork. This step has more regulatory weight than it might seem — labels typically need to carry specific mandatory information, and getting this wrong can mean reprinting everything.
6. Production. The manufacturer produces your batch, following their standard quality control process (batch testing, documentation, etc.).
7. Dispatch. The finished, packaged product ships to you or to your distribution point.

What you're responsible for vs. what the manufacturer is responsible for

This split varies by arrangement, but broadly:

• You are typically responsible for your own business-side registrations (such as GST registration) and for any brand-owner-side regulatory obligations that apply to your role in the supply chain.
• The manufacturer is typically responsible for holding and maintaining the manufacturing licences, GMP compliance, and quality control for the actual production process.

Exactly which obligations fall on which party — and what licences your specific business model requires — depends on your category, your state, and how the commercial arrangement is structured. This is genuinely worth confirming with a regulatory consultant or directly with the relevant state drug control authority before you commit, rather than assuming based on general guidance like this article.

Why brands choose this model

The appeal is straightforward: lower capital requirements, faster time to market, and the ability to focus your own effort on brand-building, distribution, and customer relationships rather than on running a factory. The trade-off is that you're depending on someone else's quality systems and capacity — which is exactly why manufacturer selection (the subject of our next guide) matters so much.

A note on this content

This article is general, informational content meant to orient someone new to the space. It is not legal, regulatory, or medical advice, and it shouldn't be the basis for a compliance decision. Specific licensing requirements, approvals, and timelines vary by product category and jurisdiction — confirm specifics with a qualified consultant or the relevant drug authority before acting.